Skip Over Navigation Links
National Institutes of Health
:
Find more NIMH pages about: Alzheimer’s Disease

Science News about Alzheimers Disease

Find Press Releases and Science Updates by Topic

Antipsychotic Medications May Ease Some Alzheimer’s Symptoms, Not Others
June 23, 2008 • Science Update
Antipsychotic medications may lessen symptoms like hostility and aggression in patients with Alzheimer’s disease, but do not appear to lessen other symptoms or improve quality of life, according to a recent analysis of data from the NIMH-funded Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer’s Disease (CATIE-AD) study. The analysis was published online ahead of print June 2, 2008, in the American Journal of Psychiatry.
Cortex Area Thinner in Youth with Alzheimer’s-Related Gene
April 24, 2007 • Press Release
A part of the brain first affected by Alzheimer’s disease is thinner in youth with a risk gene for the disorder, a brain imaging study by researchers at the National Institute of Mental Health (NIMH), one of the National Institutes of Health (NIH), has found.
Antipsychotic Medications Used to Treat Alzheimer’s Patients Found Lacking
October 11, 2006 • Press Release
Commonly prescribed antipsychotic medications used to treat Alzheimer’s patients with delusions, aggression, hallucinations, and other similar symptoms can benefit some patients, but they appear to be no more effective than a placebo when adverse side effects are considered, according to the first phase of a large-scale clinical trial funded by NIMH.
Lithium Shows Promise Against Alzheimer’s in Mouse Model
May 21, 2003 • Press Release
An enzyme crucial to formation of Alzheimer’s plaques and tangles may hold promise as a target for future medications, suggest studies in mice and cells.
Study Boosts Confidence in Potential Screening Tool for Alzheimer's Disease
April 22, 2003 • Press Release
A major study has confirmed the value of potential markers for identifying people with Alzheimer's disease.